3.2800
0.0000
(0.00%)
At close: January 29 at 8:10:46 AM GMT+1
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.81M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SCHIMMEL PAUL R Director | Purchase at price 1.74 - 1.93 per share. | Indirect | 184,613 | Jul 24, 2024 |
| DENYES NANCY General Counsel | Purchase at price 1.86 per share. | Direct | 9,276 | Jun 5, 2024 |
| SHUKLA SANJAY S Chief Executive Officer | Purchase at price 1.81 per share. | Direct | 36,140 | May 31, 2024 |
| COUGHLIN TIMOTHY P Director | Purchase at price 1.75 per share. | Indirect | 87,500 | May 30, 2024 |
| BROADFOOT JILL MARIE Chief Financial Officer | Sale at price 1.69 per share. | Direct | 2,687 | Feb 6, 2024 |
| BROADFOOT JILL MARIE Chief Financial Officer | -- | Direct | -- | Feb 5, 2024 |
| SHUKLA SANJAY S Chief Executive Officer | -- | Direct | -- | Feb 5, 2024 |
| DENYES NANCY General Counsel | -- | Direct | -- | Feb 5, 2024 |
| SHUKLA SANJAY S Chief Executive Officer | Purchase at price 1.17 - 1.18 per share. | Direct | 17,646 | Dec 12, 2023 |
| SHUKLA SANJAY S Chief Executive Officer | Purchase at price 1.11 - 1.14 per share. | Direct | 16,703 | Nov 13, 2023 |
| SHUKLA SANJAY S Chief Executive Officer | Purchase at price 2.01 per share. | Direct | 30,224 | Jul 28, 2023 |
| COUGHLIN TIMOTHY P Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 17, 2023 |
| SCHIMMEL PAUL R Director | Purchase at price 2.25 per share. | Indirect | 450,000 | May 10, 2023 |
| CLARKE JOHN K. Director | -- | Direct | -- | Apr 26, 2023 |
| SCHIMMEL PAUL R Director | -- | Direct | -- | Apr 26, 2023 |
| COUGHLIN TIMOTHY P Director | -- | Direct | -- | Apr 26, 2023 |
| ZAKNOEN SARA Director | -- | Direct | -- | Apr 26, 2023 |
| GROSS JANE A Director | -- | Direct | -- | Apr 26, 2023 |
| LUCAS SVETLANA Director | -- | Direct | -- | Apr 26, 2023 |
| BROADFOOT JILL MARIE Chief Financial Officer | Sale at price 2.36 per share. | Direct | 3,696 | Feb 6, 2023 |
| BROADFOOT JILL MARIE Chief Financial Officer | -- | Direct | -- | Feb 3, 2023 |
| SHUKLA SANJAY S Chief Executive Officer | -- | Direct | -- | Feb 3, 2023 |
| DENYES NANCY General Counsel | -- | Direct | -- | Feb 3, 2023 |
Related Tickers
1GDA.F Zevra Therapeutics, Inc.
7.45
-5.10%
6XP.SG Xspray Pharma AB (publ)
2.6800
-5.30%
F6T.MU Fate Therapeutics Inc
1.2810
0.00%
1BT.F Enlivex Therapeutics Ltd.
1.0700
-0.93%
CVAC.VI CureVac N.V.
3.7820
+0.69%
HQ1.MU Oruka Therapeutics Inc. R
11.20
0.00%
GYX.F Futura Medical plc
0.3440
+1.18%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4700
+0.64%
41X.SG Ardelyx Inc
5.24
-0.34%
IMR.F AC Immune SA
2.4650
-0.80%